Literature DB >> 10319831

Ex vivo development of a composite human oral mucosal equivalent.

K Izumi1, G Takacs, H Terashi, S E Feinberg.   

Abstract

PURPOSE: The aim of this study was the ex vivo development of a composite oral mucosal equivalent composed of a continuous stratified layer of human oral keratinocytes grown on a cadaveric human dermal matrix in a defined medium without a feeder layer.
MATERIALS AND METHODS: Enzymatically dissociated human oral keratinocytes from keratinized oral mucosa were cultured, submerged in a serum-free, low-calcium (0.15 mmol/L) supplemented medium, and expanded through several passages. Once a sufficient population of keratinocytes was reached, they were seeded on 1-cm2 pieces of AlloDerm (LifeCell Co, Woodlands, TX), an acellular nonimmunogenic cadaveric human dermis, at cell densities of 2.5 X 10(4), 5.0 X 10(4), 1.25 X 10(5), or 2.5 X 10(5). The oral keratinocyte-AlloDerm composites were cultured while submerged in a high-calcium (1.8 mmol/L) medium for 4 days. After 4 days, the composites were raised to an air-liquid interface. Samples of the composites were taken for histologic examination at 4, 11, and 18 days postseeding of the keratinocytes on the AlloDerm.
RESULTS: At day 4, only the seeded cell density of 2.5 X 10(5) cells/cm2 formed a continuous monolayer on the AlloDerm. At day 11, a continuous stratified epithelium was seen, and at day 18 a well-differentiated, confluent parakeratotic epithelial layer was developed at cell densities of 5.0 X 10(4), 1.25 X 10(5), and 2.5 X 10(5)cells/cm2.
CONCLUSION: With the method used, it was possible to successfully develop an ex vivo composite oral mucosal equivalent that consisted of a stratified epidermis on a dermal matrix.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319831     DOI: 10.1016/s0278-2391(99)90077-0

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  19 in total

Review 1.  Epithelial-mesenchymal interactions as a working concept for oral mucosa regeneration.

Authors:  Jiarong Liu; Jeremy J Mao; Lili Chen
Journal:  Tissue Eng Part B Rev       Date:  2011-01-06       Impact factor: 6.389

2.  High glucose inhibits human epidermal keratinocyte proliferation for cellular studies on diabetes mellitus.

Authors:  Hiroto Terashi; Kenji Izumi; Mustafa Deveci; Lenore M Rhodes; Cynthia L Marcelo
Journal:  Int Wound J       Date:  2005-12       Impact factor: 3.315

Review 3.  Tissue engineering of oral mucosa: a shared concept with skin.

Authors:  Beste Kinikoglu; Odile Damour; Vasif Hasirci
Journal:  J Artif Organs       Date:  2014-10-18       Impact factor: 1.731

4.  Low-level laser therapy in 3D cell culture model using gingival fibroblasts.

Authors:  Fernanda G Basso; Diana G Soares; Carlos Alberto de Souza Costa; Josimeri Hebling
Journal:  Lasers Med Sci       Date:  2016-04-28       Impact factor: 3.161

5.  Biochemical indicators of implantation success of tissue-engineered oral mucosa.

Authors:  S Kuo; Y Zhou; H M Kim; H Kato; R Y Kim; G R Bayar; C L Marcelo; R T Kennedy; S E Feinberg
Journal:  J Dent Res       Date:  2014-10-27       Impact factor: 6.116

6.  Oral mucosa-on-a-chip to assess layer-specific responses to bacteria and dental materials.

Authors:  Christopher Rahimi; Benjamin Rahimi; Dominic Padova; Seyed A Rooholghodos; Diane R Bienek; Xiaolong Luo; Gili Kaufman; Christopher B Raub
Journal:  Biomicrofluidics       Date:  2018-09-26       Impact factor: 2.800

7.  Noninvasive Optical Assessment of Implanted Engineered Tissues Correlates with Cytokine Secretion.

Authors:  Sakib F Elahi; Seung Yup Lee; William R Lloyd; Leng-Chun Chen; Shiuhyang Kuo; Ying Zhou; Hyungjin Myra Kim; Robert Kennedy; Cynthia Marcelo; Stephen E Feinberg; Mary-Ann Mycek
Journal:  Tissue Eng Part C Methods       Date:  2018-04       Impact factor: 3.056

Review 8.  Strategies for Oral Mucosal Repair by Engineering 3D Tissues with Pluripotent Stem Cells.

Authors:  Kyle J Hewitt; Yulia Shamis; Behzad Gerami-Naini; Jonathan A Garlick
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-12-01       Impact factor: 4.730

9.  [Use of buccal mucosa in urethral surgery].

Authors:  R Stein; A Schröder; J W Thüroff
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

10.  Tissue engineering of injectable soft tissue filler: using adipose stem cells and micronized acellular dermal matrix.

Authors:  Gyeol Yoo; Jin Soo Lim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.